American Academy of Allergy, Asthma & Immunology

Four Medical Societies Endorse Pre-June 2025 Respiratory Vaccine Guidance

Image
Four Medical Societies Endorse Pre-June 2025 Respiratory Vaccine Guidance

New York – November 05, 2026 -- The Vaccine Guidance Review Panel, a multi-society effort of four U.S. medical organizations, has endorsed influenza, RSV and COVID-19 vaccination recommendations for adults and children. The guidance is aligned with Advisory Committee on Immunization Practices (ACIP) recommendations issued before June 2025.

Panel draws on four specialty societies and four guidance issuers

Experts from the American Academy of Allergy, Asthma & Immunology (AAAAI), the American Thoracic Society (ATS), the American College of Chest Physicians (CHEST) and the Society of Critical Care Medicine (SCCM) reviewed the vaccination-development process. They unanimously endorsed it, together with the resulting guidance from the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), the American College of Obstetricians and Gynecologists (ACOG) and the Infectious Diseases Society of America (IDSA).

AAAAI Pushes Penicillin Allergy De-Labeling as 90% of Patients Cleared

Image
AAAAI Pushes Penicillin Allergy De-Labeling as 90% of Patients Cleared

Milwaukee – September 23, 2026 -- More than 90% of patients carrying a documented penicillin allergy in their electronic medical records can safely take the drug after clinical evaluation, according to the American Academy of Allergy, Asthma & Immunology (AAAAI), which is marking National Penicillin Allergy Day on September 28 with a push for wider adoption of allergy "de-labeling" protocols.

Inaccurate allergy labels block access to first-line infection treatment

Penicillin remains the most effective therapy for many bacterial infections, yet patients with unverified allergy labels are routinely steered toward alternative antibiotics. The AAAAI states that removing inaccurate labels through evaluation improves patient outcomes, lowers healthcare costs and supports efforts against antimicrobial resistance.